Core Insights - China Biotechnology Services (08037) announced significant progress for its flagship project, Pengbo (Hainan) Boron Neutron Hospital, located in the Boao Lecheng International Medical Tourism Pilot Zone, with the successful first beam output of the NeuCure neutron irradiation system [1] - The system is the only boron neutron capture therapy system globally that has received formal medical device registration and can be directly applied in routine clinical treatment, with clinical services expected to commence in Q1 2026 [1] - The successful beam output confirms that the core components of the system meet design specifications, marking a transition from equipment installation to beam commissioning, which is crucial for subsequent precise neutron dose rate control and biological effect evaluation [1] Company Developments - The NeuCure neutron irradiation system has entered the final clinical debugging phase, establishing a solid foundation for the hospital's future operations [1] - The project benefits from supportive policies in the Boao Lecheng International Medical Tourism Pilot Zone, enhancing its operational viability [1] - The achievement of this milestone ensures that the equipment can advance clinical treatment at a high standard, providing safe and precise boron neutron therapy services for cancer patients [1]
中国生物科技服务(08037)：硼中子治疗装置成功实现首次出束